ATRN_HUMAN - dbPTM
ATRN_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ATRN_HUMAN
UniProt AC O75882
Protein Name Attractin
Gene Name ATRN
Organism Homo sapiens (Human).
Sequence Length 1429
Subcellular Localization Isoform 1: Cell membrane
Single-pass type I membrane protein .
Isoform 2: Secreted .
Isoform 3: Secreted .
Protein Description Involved in the initial immune cell clustering during inflammatory response and may regulate chemotactic activity of chemokines. May play a role in melanocortin signaling pathways that regulate energy homeostasis and hair color. Low-affinity receptor for agouti (By similarity). Has a critical role in normal myelination in the central nervous system (By similarity)..
Protein Sequence MVAAAAATEARLRRRTAATAALAGRSGGPHWDWDVTRAGRPGLGAGLRLPRLLSPPLRPRLLLLLLLLSPPLLLLLLPCEAEAAAAAAAVSGSAAAEAKECDRPCVNGGRCNPGTGQCVCPAGWVGEQCQHCGGRFRLTGSSGFVTDGPGNYKYKTKCTWLIEGQPNRIMRLRFNHFATECSWDHLYVYDGDSIYAPLVAAFSGLIVPERDGNETVPEVVATSGYALLHFFSDAAYNLTGFNITYSFDMCPNNCSGRGECKISNSSDTVECECSENWKGEACDIPHCTDNCGFPHRGICNSSDVRGCSCFSDWQGPGCSVPVPANQSFWTREEYSNLKLPRASHKAVVNGNIMWVVGGYMFNHSDYNMVLAYDLASREWLPLNRSVNNVVVRYGHSLALYKDKIYMYGGKIDSTGNVTNELRVFHIHNESWVLLTPKAKEQYAVVGHSAHIVTLKNGRVVMLVIFGHCPLYGYISNVQEYDLDKNTWSILHTQGALVQGGYGHSSVYDHRTRALYVHGGYKAFSANKYRLADDLYRYDVDTQMWTILKDSRFFRYLHTAVIVSGTMLVFGGNTHNDTSMSHGAKCFSSDFMAYDIACDRWSVLPRPDLHHDVNRFGHSAVLHNSTMYVFGGFNSLLLSDILVFTSEQCDAHRSEAACLAAGPGIRCVWNTGSSQCISWALATDEQEEKLKSECFSKRTLDHDRCDQHTDCYSCTANTNDCHWCNDHCVPRNHSCSEGQISIFRYENCPKDNPMYYCNKKTSCRSCALDQNCQWEPRNQECIALPENICGIGWHLVGNSCLKITTAKENYDNAKLFCRNHNALLASLTTQKKVEFVLKQLRIMQSSQSMSKLTLTPWVGLRKINVSYWCWEDMSPFTNSLLQWMPSEPSDAGFCGILSEPSTRGLKAATCINPLNGSVCERPANHSAKQCRTPCALRTACGDCTSGSSECMWCSNMKQCVDSNAYVASFPFGQCMEWYTMSTCPPENCSGYCTCSHCLEQPGCGWCTDPSNTGKGKCIEGSYKGPVKMPSQAPTGNFYPQPLLNSSMCLEDSRYNWSFIHCPACQCNGHSKCINQSICEKCENLTTGKHCETCISGFYGDPTNGGKCQPCKCNGHASLCNTNTGKCFCTTKGVKGDECQLCEVENRYQGNPLRGTCYYTLLIDYQFTFSLSQEDDRYYTAINFVATPDEQNRDLDMFINASKNFNLNITWAASFSAGTQAGEEMPVVSKTNIKEYKDSFSNEKFDFRNHPNITFFVYVSNFTWPIKIQIAFSQHSNFMDLVQFFVTFFSCFLSLLLVAAVVWKIKQSCWASRRREQLLREMQQMASRPFASVNVALETDEEPPDLIGGSIKTVPKPIALEPCFGNKAAVLSVFVRLPRGLGGIPPPGQSGLAVASALVDISQQMPIVYKEKSGAVRNRKQQPPAQPGTCI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
36PhosphorylationPHWDWDVTRAGRPGL
CCCCCCCCCCCCCCC
16.60-
141PhosphorylationGRFRLTGSSGFVTDG
CCEEEECCCCEEECC
23.2724667141
142PhosphorylationRFRLTGSSGFVTDGP
CEEEECCCCEEECCC
37.2824667141
154PhosphorylationDGPGNYKYKTKCTWL
CCCCCEEEEEEEEEE
17.3326657352
156PhosphorylationPGNYKYKTKCTWLIE
CCCEEEEEEEEEEEC
28.4126657352
159PhosphorylationYKYKTKCTWLIEGQP
EEEEEEEEEEECCCC
25.5126657352
213N-linked_GlycosylationIVPERDGNETVPEVV
EECCCCCCCCCCHHH
46.16UniProtKB CARBOHYD
237N-linked_GlycosylationFFSDAAYNLTGFNIT
HHHCHHHCCCCCEEE
26.80UniProtKB CARBOHYD
242N-linked_GlycosylationAYNLTGFNITYSFDM
HHCCCCCEEEEEEEC
27.34UniProtKB CARBOHYD
253N-linked_GlycosylationSFDMCPNNCSGRGEC
EEECCCCCCCCCCEE
13.38UniProtKB CARBOHYD
264 (in isoform 3)Ubiquitination-49.3521890473
264N-linked_GlycosylationRGECKISNSSDTVEC
CCEEEECCCCCCEEE
49.3518638581
264N-linked_GlycosylationRGECKISNSSDTVEC
CCEEEECCCCCCEEE
49.3516335952
300N-linked_GlycosylationFPHRGICNSSDVRGC
CCCCCCCCCCCCCCC
42.5016335952
325N-linked_GlycosylationCSVPVPANQSFWTRE
CCCCCCCCCCCCCHH
31.77UniProtKB CARBOHYD
338 (in isoform 2)Ubiquitination-61.7721890473
338 (in isoform 1)Ubiquitination-61.7721890473
338UbiquitinationREEYSNLKLPRASHK
HHHHCCCCCCCCCCE
61.7721890473
362N-linked_GlycosylationVVGGYMFNHSDYNMV
EECCEECCCCCCCEE
19.75UniProtKB CARBOHYD
383N-linked_GlycosylationSREWLPLNRSVNNVV
CCCCCCCCCCCCCEE
32.0419139490
383N-linked_GlycosylationSREWLPLNRSVNNVV
CCCCCCCCCCCCCEE
32.0416335952
405PhosphorylationALYKDKIYMYGGKID
EEECCEEEEECCEEC
7.0429759185
407PhosphorylationYKDKIYMYGGKIDST
ECCEEEEECCEECCC
13.0229759185
416N-linked_GlycosylationGKIDSTGNVTNELRV
CEECCCCCCCCEEEE
37.2118638581
428N-linked_GlycosylationLRVFHIHNESWVLLT
EEEEEEECCEEEEEC
44.3816335952
492PhosphorylationNTWSILHTQGALVQG
CCEEEEECCCCEECC
25.8324114839
501PhosphorylationGALVQGGYGHSSVYD
CCEECCCCCCCCHHC
20.6324114839
505PhosphorylationQGGYGHSSVYDHRTR
CCCCCCCCHHCCCCC
21.0124114839
537PhosphorylationLADDLYRYDVDTQMW
ECCCEECCCCCHHHH
13.5322817900
555PhosphorylationKDSRFFRYLHTAVIV
HCCHHHHHHCEEEEE
9.55-
558PhosphorylationRFFRYLHTAVIVSGT
HHHHHHCEEEEEECC
21.74-
565PhosphorylationTAVIVSGTMLVFGGN
EEEEEECCEEEECCC
10.38-
575N-linked_GlycosylationVFGGNTHNDTSMSHG
EECCCCCCCCCHHHC
52.8216335952
623N-linked_GlycosylationGHSAVLHNSTMYVFG
CCCEECCCCCEEEEC
34.7116335952
731N-linked_GlycosylationNDHCVPRNHSCSEGQ
CCCCCCCCCCCCCCC
25.9217623646
731N-linked_GlycosylationNDHCVPRNHSCSEGQ
CCCCCCCCCCCCCCC
25.9217623646
749UbiquitinationFRYENCPKDNPMYYC
EEEECCCCCCCCEEC
72.79-
806UbiquitinationCLKITTAKENYDNAK
EEEEEECHHHCCCCE
44.38-
813UbiquitinationKENYDNAKLFCRNHN
HHHCCCCEEEECCHH
48.64-
825PhosphorylationNHNALLASLTTQKKV
CHHHHHHHHCCHHHH
26.6426074081
827PhosphorylationNALLASLTTQKKVEF
HHHHHHHCCHHHHHH
25.3726074081
828PhosphorylationALLASLTTQKKVEFV
HHHHHHCCHHHHHHH
43.6226074081
849PhosphorylationMQSSQSMSKLTLTPW
HHCCCCCCCCCCCCC
29.7530576142
863N-linked_GlycosylationWVGLRKINVSYWCWE
CCCCCCCEEEEEECC
21.51UniProtKB CARBOHYD
908PhosphorylationTRGLKAATCINPLNG
CCCCCHHHCCCCCCC
20.83-
914N-linked_GlycosylationATCINPLNGSVCERP
HHCCCCCCCCCCCCC
41.7818638581
914N-linked_GlycosylationATCINPLNGSVCERP
HHCCCCCCCCCCCCC
41.7817623646
916PhosphorylationCINPLNGSVCERPAN
CCCCCCCCCCCCCCC
23.63-
923N-linked_GlycosylationSVCERPANHSAKQCR
CCCCCCCCCCCCCCC
32.1218638581
937PhosphorylationRTPCALRTACGDCTS
CCCCHHHCCCCCCCC
27.4424114839
944PhosphorylationTACGDCTSGSSECMW
CCCCCCCCCCCCCCE
42.9024114839
953PhosphorylationSSECMWCSNMKQCVD
CCCCCEECCCHHHCC
25.1724114839
986N-linked_GlycosylationMSTCPPENCSGYCTC
CCCCCCCCCCCEECC
30.91UniProtKB CARBOHYD
1043N-linked_GlycosylationFYPQPLLNSSMCLED
CCCCCCCCCCCCCCC
39.4616335952
1054N-linked_GlycosylationCLEDSRYNWSFIHCP
CCCCCCCCEEEEECC
27.14UniProtKB CARBOHYD
1073N-linked_GlycosylationNGHSKCINQSICEKC
CCCHHHCCHHHHHHC
38.7317623646
1073N-linked_GlycosylationNGHSKCINQSICEKC
CCCHHHCCHHHHHHC
38.7317623646
1082N-linked_GlycosylationSICEKCENLTTGKHC
HHHHHCCCCCCCCCC
52.75UniProtKB CARBOHYD
1146PhosphorylationLCEVENRYQGNPLRG
EEEEEECCCCCCCCC
32.1423879269
1154PhosphorylationQGNPLRGTCYYTLLI
CCCCCCCCEEEEEEE
7.3023879269
1185PhosphorylationTAINFVATPDEQNRD
EEEEEEECCCCCCCC
26.4318452278
1198N-linked_GlycosylationRDLDMFINASKNFNL
CCHHEEEEECCCCCE
27.2217623646
1198N-linked_GlycosylationRDLDMFINASKNFNL
CCHHEEEEECCCCCE
27.2216335952
1206N-linked_GlycosylationASKNFNLNITWAASF
ECCCCCEEEEEEEEE
30.65UniProtKB CARBOHYD
1250N-linked_GlycosylationFDFRNHPNITFFVYV
CCCCCCCCEEEEEEE
38.0816335952
1259N-linked_GlycosylationTFFVYVSNFTWPIKI
EEEEEEECCCCCEEE
28.4616335952
1365MethylationLEPCFGNKAAVLSVF
EEECCCCCHHHHHHE
37.79-
1370PhosphorylationGNKAAVLSVFVRLPR
CCCHHHHHHEEECCC
13.6023403867
1418UbiquitinationSGAVRNRKQQPPAQP
CCCCCCCCCCCCCCC
57.76-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseFBXO6Q9NRD1
PMID:24658274

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ATRN_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ATRN_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of ATRN_HUMAN !!

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ATRN_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-416, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-264; ASN-300; ASN-383;ASN-416; ASN-428; ASN-575; ASN-623; ASN-1043; ASN-1198; ASN-1250 ANDASN-1259, AND MASS SPECTROMETRY.
"Screening for N-glycosylated proteins by liquid chromatography massspectrometry.";
Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
Proteomics 4:454-465(2004).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-264; ASN-383 AND ASN-731,AND MASS SPECTROMETRY.

TOP